| 20.6.2022 | EN | Official Journal of the European Union | C 237/66 |
Action brought on 25 April 2022 — Pharmaselect International v EUIPO — OmniActive Health Technologies (LUTAMAX)
(Case T-221/22)
(2022/C 237/86)
Language in which the application was lodged: English
Parties
Applicant: Pharmaselect International Beteiligungs GmbH (Vienna, Austria) (represented by: S. Jackermeier and D. Wiedemann, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: OmniActive Health Technologies Ltd (Mumbai, India)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Applicant before the General Court
Trade mark at issue: European Union word mark LUTAMAX — European Union trade mark No 3 472 974
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the First Board of Appeal of EUIPO of 24 February 2022 in Joined Cases R 524/2021-1 and R 649/2021-1
Form of order sought
The applicant claims that the Court should:
| — | annul the contested decision; |
| — | order that European Union trademark No 3 472 974 LUTAMAX remain registered for the following goods: Class 5: Medicines for human and animals use; Dietetic substances adapted for medical use; Dietary supplements adapted for medical or dietetic use; Vitamin preparations adapted for medical or dietetic use; Eye care preparations (for pharmaceutical purposes); none of the aforesaid goods for veterinary purposes; Class 29: Dietetic foodstuffs and food supplements, not adapted for medical use (included in class 29); Edible oils and fats; Class 30: Dietetic foodstuffs and food supplements, not adapted for medical use (included in class 30); |
| — | order the defendant to pay the costs of the proceedings. |
Plea in law
| — | Infringement of Article 58(1)(a) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |